Acta Otorrinolaringologica Espanola · Nov 2026

Clinical characteristics, treatment patterns, and oncological outcomes in very elderly patients (≥ 80 years) with head and neck squamous cell carcinoma

By Pérez-Ugarte L, Holgado A, Vázquez-López C et al.

Introduction Population aging has increased the number of patients with head and neck squamous cell carcinoma (HNSCC) who are very elderly (≥ 80 years). However, patients ≥ 80 years remain poorly characterized, and their clinical profile and prognosis continue to be a subject of debate. The objective of this study is to specifically analyze the characteristics and oncological outcomes of patients with HNSCC aged ≥ 80 compared with younger patients. Materials and methods We conducted a retrospective study using a prospective institutional database that included patients diagnosed with HNSCC between 1985 and 2025. Patients were grouped according to age at diagnosis (<70, 70–79, and ≥ 80 years). Clinical and tumor characteristics, treatment patterns, and survival were evaluated. Results Patients aged ≥ 80 years had a distinct clinical profile, with poorer functional status, a greater comorbidity burden, lower exposure to toxic agents, and less cervical lymph node involvement. Despite a higher proportion of early- stage disease, they showed significantly lower disease-specific survival. With increasing age, there was a progressive shift toward less intensive treatments. Age ≥ 80 years was independently associated with worse disease-specific survival, although part of this effect was mediated by functional status and comorbidity. Conclusion Patients with HNSCC aged ≥ 80 years constitute a clinically distinct population whose outcomes cannot be extrapolated from younger cohorts, supporting the need for individualized therapeutic strategies based on functional status rather than chronological age.

doi.org/10.1016/j.otorri.2026.512412Populations

AgingResearch.News